Gene Therapy Cuts Bleeding and Medicine for Hemophilia B Patients for Over a Decade

A new 13-year study published in The New England Journal of Medicine confirmed that adeno-associated virus (AAV) gene therapy—a technique using a harmless virus to deliver a working gene into the liver—can lead to long-lasting production of factor IX…